{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:13:46Z","timestamp":1777392826374,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.drudis.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:07:58Z","timestamp":1657541278000},"page":"103317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["PHLPPs: Emerging players in metabolic disorders"],"prefix":"10.1016","volume":"27","author":[{"given":"Keerthana","family":"Balamurugan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sai Latha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Swathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjunath B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parimal","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7883-2534","authenticated-orcid":false,"given":"Kishore V.L.","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","article-title":"PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth","volume":"18","author":"Gao","year":"2005","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: mechanism through structure","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2958.2004.04067.x","article-title":"Structure, function and evolution of microbial adenylyl and guanylyl cyclases","volume":"52","author":"Baker","year":"2004","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tem.2008.04.001","article-title":"PHLiPPing the switch on Akt and protein kinase C signaling","volume":"19","author":"Brognard","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0014-5793(99)01190-4","article-title":"SCOP, a novel gene product expressed in a circadian manner in rat suprachiasmatic nucleus","volume":"458","author":"Shimizu","year":"1999","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0030","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","article-title":"PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms","volume":"25","author":"Brognard","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2022.07.002_b0035","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pharmtox-011112-140338","article-title":"Turning off AKT: PHLPP as a drug target","volume":"54","author":"Newton","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"13","key":"10.1016\/j.drudis.2022.07.002_b0040","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1074\/jbc.M313283200","article-title":"Involvement of insulin\/phosphoinositide 3-kinase\/Akt signal pathway in 17\u03b2-estradiol-mediated neuroprotection","volume":"279","author":"Yu","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0092-8674(01)00594-3","article-title":"Recognizing phosphatidylinositol 3-phosphate","volume":"107","author":"Misra","year":"2001","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0092-8674(95)90219-8","article-title":"Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain","volume":"83","author":"Ferguson","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0959-440X(01)00266-4","article-title":"The leucine-rich repeat as a protein recognition motif","volume":"11","author":"Kobe","year":"2001","journal-title":"Curr Opin Struct Biol"},{"issue":"17","key":"10.1016\/j.drudis.2022.07.002_b0060","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1074\/jbc.M213214200","article-title":"Suprachiasmatic nucleus circadian oscillatory protein, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway","volume":"278","author":"Shimizu","year":"2003","journal-title":"J Biol Chem"},{"issue":"38","key":"10.1016\/j.drudis.2022.07.002_b0065","doi-asserted-by":"crossref","first-page":"E3957","DOI":"10.1073\/pnas.1404221111","article-title":"Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output","volume":"111","author":"Reyes","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6220","key":"10.1016\/j.drudis.2022.07.002_b0070","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics: tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science (80-.)"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1039\/B911410F","article-title":"SCOP\/PHLPP and its functional role in the brain","volume":"6","author":"Shimizu","year":"2010","journal-title":"Mol Biosyst"},{"issue":"10","key":"10.1016\/j.drudis.2022.07.002_b0080","article-title":"Distinct intra-mitochondrial localizations of pro-survival kinases and regulation of their functions by DUSP5 and PHLPP-1","volume":"1866","author":"Ohwada","year":"2020","journal-title":"Biochim Biophys Acta (BBA)\u2013Molecular Basis Dis"},{"issue":"267","key":"10.1016\/j.drudis.2022.07.002_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003816","article-title":"Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1","volume":"6","author":"Huang","year":"2013","journal-title":"Sci Signal"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1189\/jlb.0713360","article-title":"A novel immunomodulatory function of PHLPP1: inhibition of iNOS via attenuation of STAT1 ser727 phosphorylation in mouse macrophages","volume":"95","author":"Alamuru","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2022.07.002_b0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48609","article-title":"PHLPP1 counter-regulates STAT1-mediated inflammatory signaling","volume":"8","author":"Cohen Katsenelson","year":"2019","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.drudis.2022.07.002_b0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2017.03.080","article-title":"LPS depletes PHLPP levels in macrophages through the inhibition of SP1 dependent transcriptional regulation","volume":"486","author":"Alamuru-Yellapragada","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0105","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.joca.2015.12.014","article-title":"Phlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis","volume":"24","author":"Bradley","year":"2016","journal-title":"Osteoarthr Cartil"},{"issue":"10","key":"10.1016\/j.drudis.2022.07.002_b0110","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.1002126","article-title":"Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells","volume":"186","author":"Patterson","year":"2011","journal-title":"J Immunol"},{"issue":"51","key":"10.1016\/j.drudis.2022.07.002_b0115","doi-asserted-by":"crossref","first-page":"35283","DOI":"10.1074\/jbc.C109.078238","article-title":"Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation","volume":"284","author":"Martinez","year":"2009","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cmi.2015.10","article-title":"FOXP3+ regulatory T cells and their functional regulation","volume":"12","author":"Li","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.drudis.2022.07.002_b0125","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.18632\/oncotarget.3438","article-title":"MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K\/AKT negative regulation","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.drudis.2022.07.002_b0130","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1158\/0008-5472.CAN-13-0297","article-title":"miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer","volume":"73","author":"Cai","year":"2013","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.drudis.2022.07.002_b0135","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.18632\/oncotarget.3221","article-title":"miR-93 promotes cell proliferation in gliomas through activation of PI3K\/Akt signaling pathway","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.drudis.2022.07.002_b0140","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.27221","article-title":"MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase","volume":"60","author":"Chang","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.drudis.2022.07.002_b0145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/toxsci\/kfr188","article-title":"miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis","volume":"123","author":"Beezhold","year":"2011","journal-title":"Toxicol Sci"},{"issue":"14","key":"10.1016\/j.drudis.2022.07.002_b0150","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1074\/jbc.M112.423723","article-title":"Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp) 1 expression in chondrocytes to suppress Akt signaling and matrix secretion","volume":"288","author":"Bradley","year":"2013","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.drudis.2022.07.002_b0155","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1074\/jbc.M110.183087","article-title":"mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cmet.2008.01.008","article-title":"ATF4-mediated induction of 4E-BP1 contributes to pancreatic \u03b2 cell survival under endoplasmic reticulum stress","volume":"7","author":"Yamaguchi","year":"2008","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0212-4","article-title":"ER stress-linked autophagy stabilizes apoptosis effector PERP and triggers its co-localization with SERCA2b at ER\u2013plasma membrane junctions","volume":"5","author":"McDonnell","year":"2019","journal-title":"Cell death Discov"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0170","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.bbadis.2018.02.019","article-title":"ERK1\/2 activated PHLPP1 induces skeletal muscle ER stress through the inhibition of a novel substrate AMPK","volume":"1864","author":"Behera","year":"2018","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0175","first-page":"1","article-title":"mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2","volume":"7","author":"Kim","year":"2016","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.drudis.2022.07.002_b0180","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/MCB.00681-09","article-title":"\u03b2-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt","volume":"29","author":"Li","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.drudis.2022.07.002_b0185","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cell.2009.04.042","article-title":"Defining the human deubiquitinating enzyme interaction landscape","volume":"138","author":"Sowa","year":"2009","journal-title":"Cell"},{"issue":"48","key":"10.1016\/j.drudis.2022.07.002_b0190","doi-asserted-by":"crossref","first-page":"34545","DOI":"10.1074\/jbc.M113.503383","article-title":"WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1)","volume":"288","author":"Gangula","year":"2013","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.drudis.2022.07.002_b0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/onc.2012.66","article-title":"The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer","volume":"32","author":"Li","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/db15-0963","article-title":"Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type 1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy","volume":"65","author":"Ni","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cvr\/cvs163","article-title":"Calpains, mitochondria, and apoptosis","volume":"96","author":"Smith","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.18632\/aging.100933","article-title":"Mutual inhibition of insulin signaling and PHLPP-1 determines cardioprotective efficiency of Akt in aged heart","volume":"8","author":"Xing","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.drudis.2022.07.002_b0215","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00125-011-2116-6","article-title":"Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance","volume":"54","author":"Andreozzi","year":"2011","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0220","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00125-007-0913-8","article-title":"Isoform-specific defects of insulin stimulation of Akt\/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients","volume":"51","author":"Cozzone","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2022.07.002_b0225","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.106.615138","article-title":"Akt signaling and growth of the heart","volume":"113","author":"Walsh","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.drudis.2022.07.002_b0230","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.109.215020","article-title":"PHLPP-1 negatively regulates Akt activity and survival in the heart","volume":"107","author":"Miyamoto","year":"2010","journal-title":"Circ Res"},{"issue":"23","key":"10.1016\/j.drudis.2022.07.002_b0235","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/01.CIR.100.23.2373","article-title":"Adenoviral gene transfer of activated phosphatidylinositol 3\u2032-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro","volume":"100","author":"Matsui","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0240","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","article-title":"Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart","volume":"101","author":"Fujio","year":"2000","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.drudis.2022.07.002_b0245","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.105.595231","article-title":"Akt1 is required for physiological cardiac growth","volume":"113","author":"DeBosch","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0250","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.RES.88.6.609","article-title":"Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1","volume":"88","author":"Yamashita","year":"2001","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0255","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia\u2013reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway","volume":"61","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.drudis.2022.07.002_b0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lfs.2018.06.023","article-title":"Tumor necrosis factor-alpha upregulated PHLPP1 through activating nuclear factor-kappa B during myocardial ischemia\/reperfusion","volume":"207","author":"Tang","year":"2018","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.drudis.2022.07.002_b0265","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/onc.2013.8","article-title":"NF-\u03baB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1","volume":"33","author":"Yu","year":"2014","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.drudis.2022.07.002_b0270","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.drudis.2022.07.002_b0275","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cvr\/cvu243","article-title":"Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy","volume":"105","author":"Moc","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0280","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/cc.2.3.381","article-title":"Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival","volume":"2","author":"Matsui","year":"2003","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.drudis.2022.07.002_b0285","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI112332","article-title":"Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients","volume":"77","author":"Baggio","year":"1986","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1016\/j.drudis.2022.07.002_b0290","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1074\/jbc.M117.809913","article-title":"PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro","volume":"293","author":"Yeh","year":"2018","journal-title":"J Biol Chem"},{"issue":"6801","key":"10.1016\/j.drudis.2022.07.002_b0295","first-page":"233","volume":"407","author":"Lusis","year":"2000","journal-title":"Atherosclerosis Nature"},{"key":"10.1016\/j.drudis.2022.07.002_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103766","article-title":"PHLPP1 promotes neutral lipid accumulation through AMPK\/ChREBP dependent lipid uptake and fatty acid synthesis pathways","volume":"25","author":"Balamurugan","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0305","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2017.08.039","article-title":"Degradation of PHLPP2 by KCTD17, via a glucagon-dependent pathway, promotes hepatic steatosis","volume":"153","author":"Kim","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0310","first-page":"1","article-title":"Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.drudis.2022.07.002_b0315","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/ATVBAHA.120.314172","article-title":"Endothelial scaffolding protein ENH (enigma homolog protein) promotes PHLPP2 (pleckstrin homology domain and leucine-rich repeat protein phosphatase 2)-mediated dephosphorylation of AKT1 and eNOS (endothelial NO Synthase) promoting vascular remodeling","volume":"40","author":"Huang","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109490","article-title":"Inhibition of PHLPP1\/2 phosphatases rescues pancreatic \u03b2-cells in diabetes","volume":"36","author":"Lupse","year":"2021","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.drudis.2022.07.002_b0325","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/nm1001-1133","article-title":"Regulation of pancreatic \u03b2-cell growth and survival by the serine\/threonine protein kinase Akt1\/PKB\u03b1","volume":"7","author":"Tuttle","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2022.07.002_b0330","doi-asserted-by":"crossref","first-page":"1027386","DOI":"10.1155\/2020\/1027386","article-title":"The phosphatase PHLPP2 plays a key role in the regulation of pancreatic beta-cell survival","volume":"2020","author":"Hribal","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"11","key":"10.1016\/j.drudis.2022.07.002_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04251-0","article-title":"Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2\u03b1 phosphorylation and chemoresistance in colon cancer","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.drudis.2022.07.002_b0340","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2337\/db06-0175","article-title":"AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits","volume":"55","author":"Treebak","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2013.09.013","article-title":"AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes","volume":"382","author":"Jung","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.drudis.2022.07.002_b0350","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/db07-0843","article-title":"AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5","volume":"57","author":"McGee","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0355","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.drudis.2022.07.002_b0360","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.phrs.2016.06.028","article-title":"Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137","volume":"111","author":"Karwi","year":"2016","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0365","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/jpet.116.235119","article-title":"Cardioprotection by H2S donors: nitric oxide-dependent and-independent mechanisms","volume":"358","author":"Chatzianastasiou","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.drudis.2022.07.002_b0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-013-1946-6","article-title":"GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK\/mTOR signal pathway in H9c2 cells","volume":"389","author":"Wei","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.drudis.2022.07.002_b0375","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jss.2017.12.030","article-title":"GYY4137 protects against myocardial ischemia\/reperfusion injury via activation of the PHLPP-1\/Akt\/Nrf2 signaling pathway in diabetic mice","volume":"225","author":"Qiu","year":"2018","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0380","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.118","article-title":"Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt\/GSK3 \u03b2\/Fyn kinase axis during oxidative hepatocellular toxicity","volume":"5","author":"Rizvi","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2022.07.002_b0385","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.freeradbiomed.2018.04.550","article-title":"Activation of GSK3\u03b2\/\u03b2-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy","volume":"120","author":"Mathur","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0390","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/JOE-17-0081","article-title":"PHLPP: a putative cellular target during insulin resistance and type 2 diabetes","volume":"233","author":"Mathur","year":"2017","journal-title":"J Endocrinol"},{"issue":"8","key":"10.1016\/j.drudis.2022.07.002_b0395","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2337\/diabetes.52.8.1888","article-title":"Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity","volume":"52","author":"Short","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.drudis.2022.07.002_b0400","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/db06-1566","article-title":"Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt\/mammalian target of rapamycin signaling","volume":"56","author":"Fujita","year":"2007","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.drudis.2022.07.002_b0405","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.drudis.2022.07.002_b0410","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1111\/jcmm.15123","article-title":"Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K\/Akt\/mTOR signalling pathway in diabetic cardiomyopathy","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.drudis.2022.07.002_b0415","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1073\/pnas.0910292107","article-title":"Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock","volume":"107","author":"Masubuchi","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.drudis.2022.07.002_b0420","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/jbmr.4248","article-title":"Pleckstrin homology (PH) domain and leucine rich repeat phosphatase 1 (Phlpp1) suppresses parathyroid hormone receptor 1 (Pth1r) expression and signaling during bone growth","volume":"36","author":"Weaver","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.drudis.2022.07.002_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04196-4","article-title":"Phosphatase PHLPP2 regulates the cellular response to metabolic stress through AMPK","volume":"12","author":"Yan","year":"2021","journal-title":"Cell Death Dis"},{"issue":"24","key":"10.1016\/j.drudis.2022.07.002_b0430","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1021\/bi500428j","article-title":"Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase","volume":"53","author":"Sierecki","year":"2014","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.drudis.2022.07.002_b0435","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd.2018.201","article-title":"Phosphatases start shedding their stigma of undruggability","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"10.1016\/j.drudis.2022.07.002_b0440","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/jm100331d","article-title":"Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening","volume":"53","author":"Sierecki","year":"2010","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.drudis.2022.07.002_b0445","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/jpet.113.206888","article-title":"Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes","volume":"347","author":"Jackson","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622002872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622002872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:51Z","timestamp":1761224571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644622002872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1359644622002872"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.07.002","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PHLPPs: Emerging players in metabolic disorders","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103317"}}